SEARCH
ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Mark, Health Canada Licensed
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
June 13, 2019
iCAD Introduces ProFound AI™ for 2D Mammography in Europe
June 13, 2019
iCAD Announces Pricing Of Public Offering Of Common Stock
June 12, 2019
iCAD Announces Proposed Public Offering Of Common Stock
May 7, 2019
iCAD Reports First Quarter 2019 Financial Result
May 6, 2019
iCAD Appoints R. Scott Areglado As Chief Financial Officer
May 1, 2019
iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
